Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Abrogating mitochondrial ROS in neurons or astrocytes reveals cell-specific impact on mouse behaviour

  • Vicente-Gutiérrez, Carlos
  • Bonora, Nicoló
  • Jimenez-Blasco, Daniel
  • López-Fabuel, Irene
  • Bates, Georgina
  • Murphy, Michael P.
  • Almeida, Angeles
Cells naturally produce mitochondrial reactive oxygen species (mROS), but the in vivo pathophysiological significance has long remained controversial. Within the brain, astrocyte-derived mROS physiologically regulate behaviour and are produced at one order of magnitude faster than in neurons. However, whether neuronal mROS abundance differentially impacts on behaviour is unknown. To address this, we engineered genetically modified mice to down modulate mROS levels in neurons in vivo. Whilst no alterations in motor coordination were observed by down modulating mROS in neurons under healthy conditions, it prevented the motor discoordination caused by the pro-oxidant neurotoxin, 3-nitropropionic acid (3-NP). In contrast, abrogation of mROS in astrocytes showed no beneficial effect against the 3-NP insult. These data indicate that the impact of modifying mROS production on mouse behaviour critically depends on the specific cell-type where they are generated., J.P.B. is funded by the Agencia Estatal de Investigación (SAF2016-78114-R, PID2019-105699RB-I00/AEI/10.13039/501100011033 and RED2018-102576-T), Plan Nacional sobre Drogas (2020I028), ISCIII (CB16/10/00282), Junta de Castilla y Le ́on (Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Biomedicina 2017 Fundaci ́on BBVA and Fundaci ́on Ram ́on Areces. A.A. is funded by the ISCIII (PI18/00265, RD16/0019/0018), AEI (SAF2017-90794-REDT) and European Union’s Horizon 2020 Research and Innovation Program (Grant Agreement 686009). J.P.B. and A.A. are funded by the grant CSI151P20 from the Junta de Castilla y Leon.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mitochondrial–nuclear p53 trafficking controls neuronal susceptibility in stroke

  • Almeida, Angeles
  • Sánchez Morán, Irene
  • Rodríguez González, Cristina
Stroke is a major cause of death and long-term disability in the adult. Neuronal apoptosis plays an essential role in the pathophysiology of ischemic brain damage and impaired functional recovery after stroke. The tumor suppressor protein p53 regulates key cellular processes, including cell cycle arrest, DNA repair, senescence, and apoptosis. Under cellular stress conditions, p53 undergoes post-translational modifications, which control protein localization, stability, and proapoptotic activity. After stroke, p53 rapidly accumulates in the ischemic brain, where it activates neuronal apoptosis through both transcriptional-dependent and -independent programs. Over the last years, subcellular localization of p53 has emerged as an important regulator of ischemia-induced neuronal apoptosis. Upon an ischemic insult, p53 rapidly translocates to the mitochondria and interacts with B-cell lymphoma-2 family proteins, which activate the mitochondrial apoptotic program, with higher efficacy than through its activity as a transcription factor. Moreover, the identification of a human single nucleotide polymorphism at codon 72 of the Tp53 gene that controls p53 mitochondrial localization and cell susceptibility to apoptosis supports the important role of the p53 mitochondrial program in neuronal survival and functional recovery after stroke. In this article, we review the relevance of mitochondrial and nuclear localization of p53 on neuronal susceptibility to cerebral ischemia and its impact on functional outcome of stroke patients., Consejería de Educación, Junta de Castilla y León, Grant/Award Numbers: CLU-2017-03, CSI151P20; EU Horizon 2020Research and Innovation Programme,Grant/Award Number: GA 686009;Ministerio de Ciencia e Innovación,Grant/Award Number:SAF2017-90794-REDT to AA; Junta deCastilla y León; Horizon 2020; EuropeanUnion; European Regional DevelopmentFund; Instituto de Salud Carlos III, Grant/Award Numbers: PI18/00265,RD16/0019/0018
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Oxidative stress-triggered nuclear WRAP53 translocation promotes neuronal survival and functional recovery after stroke

  • Sánchez Morán, Irene
  • Rodríguez González, Cristina
  • Bolaños, Juan P.
  • Almeida, Angeles
Trabajo presentado en la 20th Biennial Meeting of The Society for Free Radical Research International (SFRR-I) celebrada online del 15 al 18 de marzo de 2021, Ischemic stroke is the leading cause of neurologic death and long-term adult disability worldwide. Ischemia-induced oxidative stress compromises genome integrity, resulting in DNA damage. Failure of neurons to efficiently repair DNA double-strands breaks (DSB) contributes to cerebral damage and impairs functional recovery after stroke. However, the molecular machinery that regulates DNA repair in this neurological disorder remains unknown. Here we describe that WRAP53 (WD40 encoding RNA Antisense to p53), a scaffold protein implicated in telomere elongation and DNA repair in tumor cells, plays an essential role in neuronal survival after ischemia. We found that experimental ischemia, performed by oxygen and glucose deprivation (OGD), promoted oxidative stress-induced DSB in neurons. These events spatiotemporally correlated with WRAP53 upregulation and nuclear translocation to activate DSBs repair response. Mechanistically, OGD triggered a burst in reactive oxygen species that induced both DSB and translocation of WRAP53 to the nucleus to promote DNA repair, a pathway that was confirmed in an in vivo mouse model of stroke. Noticeably, nuclear translocation of WRAP53 occurred faster in OGD neurons expressing the Wrap53 human nonsynonymous single-nucleotide polymorphism (SNP) rs2287499 (c.202C>G). Patients carrying this SNP showed less infarct volume and better functional outcome after stroke. These results provide a new signaling role for reactive oxygen species in the mechanism of DSB repair in neurons and unravel the role of WRAP53 to maintaining genome integrity and survival after stroke., This work was funded by the Instituto de Salud Carlos III (PI18/00265 and RD16/0019/0018), European Regional Development Fund (FEDER), Ministerio de Ciencia en Innovación (SAF2017-90794-REDT), European Union’s Horizon 2020 Research and Innovation Programme (grant agreement 686009), Junta de Castilla y León (IES007P17 and Escalera de Excelencia CLU-2017-03 Cofinanciado por el P.O. FEDER de Castilla y León), and Fundación Ramón Areces.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Oral Anticoagulation and Risk of Symptomatic Hemorrhagic Transformation in Stroke Patients Treated With Mechanical Thrombectomy: Data From the Nordictus Registry

  • Ramos-Araque, M.E.
  • Chavarría-Miranda, A.
  • Gómez-Vicente, B.
  • López-Cancio Martínez, E.
  • Castañón Apilánez, M.
  • Castellanos, M.
  • López Fernández, M.
  • Tejada Meza, H.
  • Marta Moreno, J.
  • Tejada García, J.
  • Beltrán Rodríguez, I.
  • de la Riva, P.
  • Díez, N.
  • Arias Rivas, S.
  • Santamaría Cadavid, M.
  • Bravo Anguiano, Y.
  • Bártulos Iglesias, M.
  • Palacio Portilla, E.J.
  • Revilla García, M.
  • Timiraos Fernández, J.J.
  • Arenaza Basterrechea, N.
  • Maciñeiras Montero, J.L.
  • Vicente Alba, P.
  • Julián Villaverde, F.J.
  • Pinedo Brochado, A.
  • Azkune, I.
  • Mar, F.M.
  • Luna, A.
  • Arenillas, J.F.
Introduction: We aimed to evaluate if prior oral anticoagulation (OAC) and its type determines a greater risk of symptomatic hemorrhagic transformation in patients with acute ischemic stroke (AIS) subjected to mechanical thrombectomy. Materials and Methods: Consecutive patients with AIS included in the prospective reperfusion registry NORDICTUS, a network of tertiary stroke centers in Northern Spain, from January 2017 to December 2019 were included. Prior use of oral anticoagulants, baseline variables, and international normalized ratio (INR) on admission were recorded. Symptomatic intracranial hemorrhage (sICH) was the primary outcome measure. Secondary outcome was the relation between INR and sICH, and we evaluated mortality and functional outcome at 3 months by modified Rankin scale. We compared patients with and without previous OAC and also considered the type of oral anticoagulants. Results: About 1.455 AIS patients were included, of whom 274 (19%) were on OAC, 193 (70%) on vitamin K antagonists (VKA), and 81 (30%) on direct oral anticoagulants (DOACs). Anticoagulated patients were older and had more comorbidities. Eighty-one (5.6%) developed sICH, which was more frequent in the VKA group, but not in DOAC group. OAC with VKA emerged as a predictor of sICH in a multivariate regression model (OR, 1.89 [95% CI, 1.01–3.51], p = 0.04) and was not related to INR level on admission. Prior VKA use was not associated with worse outcome in the multivariate regression model nor with mortality at 3 months. Conclusions: OAC with VKA, but not with DOACs, was an independent predictor of sICH after mechanical thrombectomy. This excess risk was associated neither with INR value by the time thrombectomy was performed, nor with a worse functional outcome or mortality at 3 months.